David Tepper Says He’s Buying Stocks After Market’s Worst Week in a Decade (CNBC) Hedge fund manager David Tepper said Monday he is buying some stocks......
(read more)December 24 - Hedge Funds, Insider Trading - Comments
A market correction in the fourth quarter, spurred by a number of global macroeconomic concerns and rising interest rates ended up having a negative impact......
(read more)December 13 - Hedge Funds, News - Comments
Activist Investor Litt Renews Call for Saks Fifth Avenue Sale (Reuters) Nov 28 (Reuters) – Activist investor Jonathan Litt on Wednesday renewed......
(read more)November 28 - Hedge Funds, Insider Trading - Comments
Sarissa Capital Management is a Greenwich, Connecticut-based activist hedge fund established in 2012 by its current chief investment officer, Dr. Alexander......
(read more)October 31 - Hedge Funds, News - Comments
Tenax Therapeutics Inc (NASDAQ:TENX) (Benzinga) Tenax Therapeutics Inc shares surged 140.5 percent to $ 11.16 as the company reported the publication......
(read more)March 1 - Market Movers, News - Comments
You probably haven’t heard of Alex Denner‘s Sarissa Capital Management, which is a shame, as the fund is coming off a first-quarter in which......
(read more)May 16 - Hedge Fund Analysis, Hedge Funds, News - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......
(read more)May 1 - Hedge Funds - Comments
Although all three major indexes have rebounded into the green this afternoon, shares of five companies, Amgen, Inc. (NASDAQ:AMGN), Esperion Therapeutics......
(read more)March 17 - Market Movers, News - Comments
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research......
(read more)December 2 - Hedge Funds, News - Comments
We’ve had another big day in biotech, and a number of companies have moved on news and fundamental developments. The political influence is starting......
(read more)November 17 - Market Movers, News, Stock Analysis - Comments
The majority of hedge funds and other top money managers tend to have a long-term focus when they make investments. This means that retail investors can......
(read more)November 4 - Hedge Fund Analysis, Hedge Funds, News - Comments
The Medicines Company (NASDAQ:MDCO) just put out topline from its lead cholesterol trial, and the company has jumped on the back of the data. The release......
(read more)October 19 - News, Stock Analysis - Comments
Many traders are watching crude futures today to see if WTI can break out of the $50 per barrel mark. On one hand, there will likely be strong resistance......
(read more)October 6 - Market Movers, News - Comments
While Securities and Exchange Commission rules require executives, directors and other insiders to report purchases or sales in their own company’s......
(read more)June 9 - Insider Trading, News - Comments
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Micron and Anadarko Petroleum, have not done well during......
(read more)November 23 - Hedge Funds, News - Comments
On August 30, The Medicines Company (NASDAQ:MDCO) and Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) announced positive initial results from their ongoing......
(read more)August 31 - Hedge Funds, News - Comments
Camber Capital Management is a hedge fund headquartered in Boston and founded by Stephen DuBois. The hedge fund is considered as an activist due to activist......
(read more)June 23 - Hedge Funds, News - Comments
Roberto Mignone‘s Bridger Management is a fund with around $2.0 billion in assets, one that is focused on healthcare stocks, which represent nearly......
(read more)March 3 - Hedge Funds, News - Comments
In the last few days, we have seen a lot of capital from funds that we track getting shifted to pharmaceutical stocks and no it’s not just sector specific......
(read more)October 21 - Hedge Funds, News - Comments
Led by Sean Cullinan, Point State Capital revealed a significantly increased position in The Medicines Company (NASDAQ:MDCO). The updated position......
(read more)April 4 - Hedge Funds, News - Comments
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age. Although there are more than 8,000 hedge......
(read more)August 29 - News - Comments
In the eyes of many investors, hedge funds are perceived as bloated, outdated financial vehicles of a forgotten age. Although there are In excess of 8......
(read more)August 28 - News - Comments
If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time. Although there......
(read more)August 26 - News - Comments
Is Amarin Corporation plc (ADR) (NASDAQ:AMRN) a buy? In the financial world, there are many metrics shareholders can use to track their holdings. A duo......
(read more)August 23 - News - Comments
The Medicines Company (NASDAQ:MDCO) is a mid-cap value stock that jumped by 21% in the last 12 months, trading at a 52-week price range of $20.04-$37.......
(read more)August 23 - News - Comments
Shares of biotech Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) have soared over 160% in the past year. The company’s a leader in developing drugs......
(read more)June 20 - News - Comments
The Medicines Company (NASDAQ:MDCO) shareholders have witnessed an increase in activity from the world’s largest hedge funds lately. According to......
(read more)March 29 - News - Comments
Earnings and earning-related news is the number one catalyst for stock movement. A strong quarter can dictate the direction of a stock for the following......
(read more)February 21 - News - Comments
